Site logo
Sticky header logo
Site logo
Sticky header logo
Mobile logo
  • Our science
  • The Cytonians
  • In the news
  • Media
  • Our commitment

Author Archives: Mike

In the news Cytonus Therapeutics expands C-suite as it transitions to a clinical stage company
April 22, 2024in In the news 0 Comments 0 Likes

Cytonus Therapeutics expands C-suite as it transitions to a clinical stage company

by Mike
In the news Cytonus Therapeutics Enters Licensing Agreement with Medinno for HIEstem™, a Neuro-Regenerative Cellular Therapy
January 9, 2024in In the news 0 Comments 0 Likes

Cytonus Therapeutics Enters Licensing Agreement with Medinno for HIEstem™, a Neuro-Regenerative Cellular Therapy

by Mike
Uncategorized San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines
December 4, 2023in Uncategorized 0 Comments 0 Likes

San Diego biotech raises $11.7M to use cells as targeted delivery vessels for genetic medicines

by Mike
The Cytonus team Cytonus expands its Scientific Advisory Board with Oncolytic Virus expert John C. Bell, PhD.
November 15, 2023in The Cytonus team 0 Comments 0 Likes

Cytonus expands its Scientific Advisory Board with Oncolytic Virus expert John C. Bell, PhD.

by Mike
Uncategorized Cytonus selected by Fierce Life Sciences as a finalist for their annual Innovation Awards
October 14, 2022in Uncategorized 0 Comments 0 Likes

Cytonus selected by Fierce Life Sciences as a finalist for their annual Innovation Awards

by Mike
Events Cytonus Therapeutics to Present Cargocyte™ Drug-Delivery Data at the ASGCT 25th Annual Meeting
May 12, 2022in Events 0 Comments 0 Likes

Cytonus Therapeutics to Present Cargocyte™ Drug-Delivery Data at the ASGCT 25th Annual Meeting

by Mike
Events Cytonus Therapeutics to Present Preclinical Data for Cargocyte™ CA-IL-12 for Treating Immune Checkpoint Inhibitor-Resistant Late Stage Metastatic Cancers at AACR 2022
March 29, 2022in Events 0 Comments 0 Likes

Cytonus Therapeutics to Present Preclinical Data for Cargocyte™ CA-IL-12 for Treating Immune Checkpoint Inhibitor-Resistant Late Stage Metastatic Cancers at AACR 2022

by Mike
In the news Cytonus announces Nature Biomedical Engineering publication
December 21, 2021in In the news 0 Comments 0 Likes

Cytonus announces Nature Biomedical Engineering publication

by Mike
The Cytonus team Cytonus expands its Scientific Advisory Board with City of Hope’s Stephen Forman, MD and NYU’s Robert Schneider, PhD
March 17, 2020in The Cytonus team 0 Comments 0 Likes

Cytonus expands its Scientific Advisory Board with City of Hope’s Stephen Forman, MD and NYU’s Robert Schneider, PhD

by Mike
The Cytonus team Cytonus appoints Allergan executive Manisha Narasimhan, Ph.D. to its Board of Directors
March 10, 2020in The Cytonus team 0 Comments 0 Likes

Cytonus appoints Allergan executive Manisha Narasimhan, Ph.D. to its Board of Directors

by Mike
Prev

Posts navigation

  • 1
  • 2
Next
Archives
  • April 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2022
  • May 2022
  • March 2022
  • December 2021
  • March 2020
  • February 2020
  • January 2020
  • April 2019
  • March 2019
  • February 2019
Categories
  • Events
  • In the news
  • Interviews & Spotlights
  • Partnerships
  • The Cytonus team
  • Uncategorized
Contact us

Headquarters
3280 Grey Hawk Court
Carlsbad, CA 92010

Email
  • Partnership inquiries
  • Media inquiries
  • Investor relationships
Social media
© 2022 Cytonus Therapeutics, Inc. All rights reserved. | Terms of use | FCOI policy
div#stuning-header .dfd-stuning-header-bg-container {background-size: cover;background-position: center center;background-attachment: scroll;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 620px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}